Lunai Bioworks Inc. (LNAI)
NASDAQ: LNAI · Real-Time Price · USD
1.160
+0.130 (12.62%)
At close: Nov 18, 2025, 4:00 PM EST
1.150
-0.010 (-0.86%)
After-hours: Nov 18, 2025, 5:34 PM EST

Lunai Bioworks Statistics

Total Valuation

Lunai Bioworks has a market cap or net worth of $26.89 million. The enterprise value is $25.96 million.

Market Cap26.89M
Enterprise Value 25.96M

Important Dates

The next estimated earnings date is Friday, February 13, 2026, after market close.

Earnings Date Feb 13, 2026
Ex-Dividend Date n/a

Share Statistics

Lunai Bioworks has 23.18 million shares outstanding. The number of shares has increased by 49.41% in one year.

Current Share Class 23.18M
Shares Outstanding 23.18M
Shares Change (YoY) +49.41%
Shares Change (QoQ) +27.87%
Owned by Insiders (%) 30.77%
Owned by Institutions (%) 5.01%
Float 13.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio 0.04
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -25.58

Financial Efficiency

Return on equity (ROE) is -308.01% and return on invested capital (ROIC) is -20.86%.

Return on Equity (ROE) -308.01%
Return on Assets (ROA) -14.85%
Return on Invested Capital (ROIC) -20.86%
Return on Capital Employed (ROCE) 119.88%
Revenue Per Employee n/a
Profits Per Employee -$4.52M
Employee Count29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -76.93% in the last 52 weeks. The beta is 0.39, so Lunai Bioworks's price volatility has been lower than the market average.

Beta (5Y) 0.39
52-Week Price Change -76.93%
50-Day Moving Average 1.27
200-Day Moving Average 3.58
Relative Strength Index (RSI) 52.95
Average Volume (20 Days) 9,058,919

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -15.30M
Pretax Income -130.98M
Net Income -130.98M
EBITDA -15.16M
EBIT -15.30M
Earnings Per Share (EPS) -$7.22
Full Income Statement

Balance Sheet

The company has $624,808 in cash and $2.71 million in debt, giving a net cash position of -$2.08 million or -$0.09 per share.

Cash & Cash Equivalents 624,808
Total Debt 2.71M
Net Cash -2.08M
Net Cash Per Share -$0.09
Equity (Book Value) -13.04M
Book Value Per Share -0.56
Working Capital -18.92M
Full Balance Sheet

Cash Flow

Operating Cash Flow -7.21M
Capital Expenditures n/a
Free Cash Flow -7.21M
FCF Per Share -$0.31
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Lunai Bioworks does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -49.41%
Shareholder Yield -49.41%
Earnings Yield -548.63%
FCF Yield -30.19%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 30, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date Sep 30, 2025
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 1